Quality-of-Life in CRPC Patients Treated With Enzalutamide Versus Abiraterone: Impact of Standard and Modified Dosing.

Clin Genitourin CancerJul 4, 2026 (epub)
Clinical ResearchOncology (Medical)

Shuichi Tatarano, Kouji Izumi, Hideki Enokida et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial compared the quality of life (QoL) in patients with castration-resistant prostate cancer (CRPC) treated with enzalutamide (ENZ) versus abiraterone (ABI). Among 89 patients in each arm, ABI significantly deteriorated QoL over time, while ENZ maintained QoL. The total FACT-G score for ABI worsened with standard dosing (P = .0003), but not with modified dosing.

Key findings

  • ABI significantly deteriorated total FACT-G score over time (P = .0003).
  • ENZ did not change the total FACT-G score during treatment (P = .9585).
  • Standard dose of ABI worsened social and functional well-being (P = .0010 and P < .0001).
  • Modified dose of ABI did not deteriorate social or functional well-being (P = .6549 and P = .5837).

Why it matters

Understanding the impact of different treatments on quality of life is crucial for clinicians managing CRPC. This study highlights that while both treatments offer similar survival benefits, their effects on QoL can differ significantly, influencing treatment choices.

Source

PubMed · PMID 42509097

Published in Clin Genitourin Cancer. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Clinical ResearchPreventive Medicine / Public Health

2025 National Guidelines on the Mediterranean Diet: Executive Summary of a Joint Report by Italian Scientific Societies and the National Institute of Health Task Force on Clinical Practice Guidelines.

This systematic review and practice guideline, developed by a multidisciplinary panel using NUTRIGRADE, assessed Mediterranean diet evidence across nine health domains and one economic domain.

Nutr RevNov 12, 2026Read summary
Clinical ResearchOrthopedic Surgery

Prevention of Venous Thromboembolism after Total Hip or Knee Replacement.

This multicenter randomized comparative-effectiveness noninferiority trial compared 30 days of aspirin, warfarin, or rivaroxaban for VTE prophylaxis after elective total hip or knee arthroplasty.

N Engl J MedNov 12, 2026Read summary
Clinical ResearchAnesthesiology

Effect of discontinuing antihypertensives on perioperative hypotension in older patients before non-cardiac surgery: multicentre, randomised, double blind, controlled trial.

This multicentre, randomised, double blind, placebo controlled trial assessed whether withholding ACE inhibitors or ARBs on the morning of surgery reduces perioperative hypotension in older adults undergoing non-cardiac…

BMJNov 11, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.